Presented by
Naomi Zak

Nominated by
Weizmann Institute of Science

 

BiomX is a microbiome drug discovery company developing customised phage therapies that seek and destroy harmful bacteria linked to chronic diseases, such as inflammatory bowel disease (IBD) and cancer. The microbiome refers to the bacteria residing in and on the human body. Microbiome research constitutes a new and fast-developing field, and it offers a novel approach to address various diseases. Research has found growing evidence for the presence of harmful bacteria in the microbiome in chronic diseases such as cancer and IBD. In these cases, antibiotics are not a viable solution because they increase antimicrobial resistance and disrupt the microbiome. Bacteriophages (bacterial viruses), however, offer a selective and targeted means to eradicate specific bacterial strains. BiomX uses novel computational and synthetic biology to discover and validate proprietary bacterial targets and to customise their natural and engineered phage compositions to attack these targets. BiomX’s innovative therapies thus address the unmet needs of millions of patients worldwide suffering from cancer, IBD, and other chronic diseases.

More Venture Finalists

All Venture Finalists

Further Activities to have a look at

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Privacy Preference Center

We use cookies and other technologies to collect data about your use of our site and about your browser, device and location. We process this data to help us understand how the site is used and to personalize our content and the advertising you see on this and other sites we also share this data with advertising, social media and analytics partners for the same purposes. By choosing “Accept All” you agree that we store cookies on your device and process the data for the aforementioned purposes . You may revoke your consent at any time by choosing the respective settings. For more information on the processing of personal data and what specific services we use see our Privacy Policy

Necessary Cookies

These cookies are required to provide you with our site and its functions. Since storing these cookies is necessary for the provision of our site and its functions, you cannot disable them. If you block these cookies via you browser settings our site may not function properly.

Analyse Cookies

These cookies enable us to use website analytics in order to improve our site or provide you with personalized content. They may be set by us or by third party providers whose services we have added to our pages.

Marketing Cookies

These cookies enable us to use online marketing and advertising in order to provide you on this or on other sites with personalized advertisement. They may be set by us or by third party providers whose services we have added to our pages.